Last updated: 11/07/2018 19:34:55
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack
Trial description: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
A randomized, double blind, placebo controlled, parallel group evaluation of sumatriptan 50 mg and 100 mg tablets administered during the mild pain phase of a menstrually associated migraine attack. Savani, N, Loftus, J, and Boswell, J 14th Migraine Trust International Symposium: Research is the Key 9/23/2002 London; UK
Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Landy, S., Savani, N., Shackelford, S., Loftus, J., and Jones, M. Int J Clin Pract 2004; 58(10):913-9
Pain free efficacy of sumatriptan in the treatment of menstrually-associated migraine. Nett, Robert , Landy, Steve, Shackelford, Steve, Richardson, Mary S., and Ames, Michael. 55th Annual Meeting of the American Academy of Neurology 3/29/2003 Honolulu, HI; USA
Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Nett, R., Landy, S., Shackelford, S., Richardson, M. S., Ames, M., and Lener, M. Obstet Gynecol 2003; 102(4):835-42
Medical condition
Migraine Disorders
Product
sumatriptan
Collaborators
Not applicable
Study date(s)
July 2001 to January 2002
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2002-18-01
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website